Literature DB >> 16176425

Potential etiologies of biliary atresia.

Jorge A Bezerra1.   

Abstract

Biliary atresia is the most common cause of neonatal cholestasis and the leading indication for pediatric liver transplantation worldwide. The disease is caused by a progressive inflammatory and fibrosing obliteration of the extrahepatic bile ducts. Although the cause of this obstruction is largely unknown, patient-based studies have identified environmental and genetic factors that may interact and orchestrate disease pathogenesis. Chief among these factors are infectious and immunologic processes. While infectious agents have varied in different patient populations, studies of liver specimens at different phases of disease point to a pro-inflammatory commitment of lymphocytes at the time of diagnosis, and to their potential role in regulating bile duct obstruction. A review of these studies is the focus of this article.

Entities:  

Mesh:

Year:  2005        PMID: 16176425     DOI: 10.1111/j.1399-3046.2005.00350.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  30 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  The outcome of laparoscopic portoenterostomy for biliary atresia in children.

Authors:  Kin Wai Edwin Chan; Kim Hung Lee; Jennifer Wai Cheung Mou; Sing Tak Gloria Cheung; Yuk Him Peter Tam
Journal:  Pediatr Surg Int       Date:  2011-02-01       Impact factor: 1.827

3.  Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish.

Authors:  Xiao Zhao; Kristin Lorent; Benjamin J Wilkins; Dylan M Marchione; Kevin Gillespie; Orith Waisbourd-Zinman; Juhoon So; Kyung Ah Koo; Donghun Shin; John R Porter; Rebecca G Wells; Ian Blair; Michael Pack
Journal:  Hepatology       Date:  2016-06-11       Impact factor: 17.425

4.  Identification of a plant isoflavonoid that causes biliary atresia.

Authors:  Kristin Lorent; Weilong Gong; Kyung A Koo; Orith Waisbourd-Zinman; Sara Karjoo; Xiao Zhao; Ian Sealy; Ross N Kettleborough; Derek L Stemple; Peter A Windsor; Stephen J Whittaker; John R Porter; Rebecca G Wells; Michael Pack
Journal:  Sci Transl Med       Date:  2015-05-06       Impact factor: 17.956

Review 5.  Paediatric liver ultrasound: a pictorial essay.

Authors:  Marco Di Serafino; Rosa Severino; Matilde Gioioso; Eugenio Rossi; Norberto Vezzali; Piernicola Pelliccia; Maria Grazia Caprio; Ciro Acampora; Raffaele Iorio; Gianfrancio Vallone
Journal:  J Ultrasound       Date:  2019-02-18

Review 6.  MicroRNAs and benign biliary tract diseases.

Authors:  Sergio A Gradilone; Steven P O'Hara; Tetyana V Masyuk; Maria Jose Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 7.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

8.  A Point Mutation in the Rhesus Rotavirus VP4 Protein Generated through a Rotavirus Reverse Genetics System Attenuates Biliary Atresia in the Murine Model.

Authors:  Sujit K Mohanty; Bryan Donnelly; Phylicia Dupree; Inna Lobeck; Sarah Mowery; Jaroslaw Meller; Monica McNeal; Greg Tiao
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

9.  Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes.

Authors:  Inna Lobeck; Bryan Donnelly; Phylicia Dupree; Maxime M Mahe; Monica McNeal; Sujit K Mohanty; Greg Tiao
Journal:  Virology       Date:  2016-09-23       Impact factor: 3.616

10.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.